Burjeel recorded a remarkable 129% rise in net profit in the second quarter of 2025, reaching AED 148 million. The jump shows how more people are turning to the group for specialized care, as it continues to invest in high-value healthcare services that meet growing patient needs.
The UAE-based healthcare operator continues to strengthen its reputation as a leader in complex medical care. Patients are increasingly turning to Burjeel for advanced treatments, especially in areas like cancer and mental health.
A major driver of this growth is the expansion of the Advanced Care Oncology Center. This facility, part of the Burjeel network, is setting new standards for cancer care in the region. It offers tailored oncology services backed by cutting-edge technology and internationally trained specialists.
The group has also opened Burjeel Cancer Institute clinics in Sharjah, Al Ain, and Oman. This makes it easier for more patients to get expert care closer to home. Burjeel wants to build a network of specialty care across the whole region, and these new clinics are a part of that plan.
Advanced Care Oncology Center Fuels Burjeel’s Growth
The Advanced Care Oncology Center has played a vital role in attracting patients seeking high-end, personalized cancer treatment. Its focus on early diagnosis, precision medicine, and holistic patient support is helping Burjeel grow not just financially, but in public trust as well.
Beyond oncology, Burjeel is tapping into other critical areas. It recently launched a new mental health platform in collaboration with Alkalma, a joint venture. The initiative has already led to the opening of four specialized mental wellness centers across the UAE and Saudi Arabia, a timely move given the rising awareness of mental health in the region.
Burjeel has also optimized its physical assets. The company acquired the building housing Medeor Hospital Dubai, which will cut long-term rental costs and improve operational efficiency.
Overall, Burjeel’s Q2 2025 revenue rose 18.7% year-on-year to AED 1.403 billion. Its EBITDA surged 59%, reaching AED 306 million. These strong results are powered by rising patient volumes and better profit margins from premium services.
The Abu Dhabi-listed firm is also seeing positive market reactions. After the earnings release, Burjeel’s stock price climbed nearly 5% on the ADX, a sign that investors are backing the group’s strategy of growth through specialization.
Looking ahead, Burjeel plans to continue investing in advanced care and specialty medical services. With the Advanced Care Oncology Center leading the way, the company is not just treating patients; it’s reshaping healthcare standards across the region.
